Digital attribution is primarily associated with paid digital media and associated online click behavior. It is assumed that digital is effective, and since it saves cost of delivery of information it would be an effective channel. Pharmaceutical companies has absolutely no insight into how the digital interaction with the physician and the patient drives the efficacy of their current sales levers. At Kvantum, we help Pharma companies in answering questions like:
Does digital affect the need to reallocate spend on detailing vs sampling
Which type of digital interaction has the most impact on physician behavior when prescribing a drug, and how much time does it take digital interaction to influence that behavior
Does this behavior change with time?
Should the pharmaceutical company invest more in sales reps who can interact with a physician over email or chat?
Should the field sales rep call or meet less often, should part of these meetings be conducted over a digital medium
Bottomline, the effect of digital on sales in an unknown